The future of dry powder inhaled therapy: Promising or discouraging for systemic disorders?

Y Ye, Y Ma, J Zhu - International journal of pharmaceutics, 2022 - Elsevier
Dry powder inhalation therapy has been shown to be an effective method for treating
respiratory diseases like asthma, Chronic Obstructive Pulmonary Diseases and Cystic …

The management of psychomotor agitation associated with schizophrenia or bipolar disorder: a brief review

M Pompili, G Ducci, A Galluzzo, G Rosso… - International Journal of …, 2021 - mdpi.com
The early and correct assessment of psychomotor agitation (PMA) is essential to ensure
prompt intervention by healthcare professionals to improve the patient's condition, protect …

Effect of sublingual dexmedetomidine vs placebo on acute agitation associated with bipolar disorder: a randomized clinical trial

SH Preskorn, S Zeller, L Citrome, J Finman… - Jama, 2022 - jamanetwork.com
Importance Acute agitation is common in patients with bipolar disorder and requires urgent
management to relieve distress and to prevent escalation to aggressive behavior. Objective …

Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice

H Weng, W Zou, F Tian, H Xie, A Liu, W Liu… - Nature …, 2024 - nature.com
Heart failure causes considerable morbidity and mortality worldwide. Clinically applied
drugs for the treatment of heart failure are still severely limited by poor delivery efficiency to …

[HTML][HTML] Sublingual dexmedetomidine for the treatment of acute agitation in adults with schizophrenia or schizoaffective disorder: a randomized placebo-controlled trial

L Citrome, SH Preskorn, J Lauriello… - The Journal of …, 2022 - legacy.psychiatrist.com
Objective: Determine if sublingual dexmedetomidine, a selective α 2 adrenergic receptor
agonist, reduces symptoms of acute agitation associated with schizophrenia or …

Sublingual dexmedetomidine for agitation associated with schizophrenia or bipolar disorder: a post hoc analysis of number needed to treat, number needed to harm …

L Citrome, R Risinger, L Rajachandran, H Robison - Advances in Therapy, 2022 - Springer
Introduction The objective was to use the evidence-based medicine metrics of number
needed to treat, number needed to harm, and likelihood to be helped or harmed to appraise …

Moving towards optimized noncommunicable disease management in the ASEAN region: Recommendations from a review and multidisciplinary expert panel

NT Castillo-Carandang, RD Buenaventura… - … and Healthcare Policy, 2020 - Taylor & Francis
Introduction Noncommunicable diseases (NCDs) are the leading cause of morbidity and
mortality in the Association of Southeast Asian Nations (ASEAN) member states. Progress …

Integrated management of multiple sclerosis spasticity and associated symptoms using the spasticity-plus syndrome concept: results of a structured specialists' …

O Fernandez, L Costa-Frossard… - Frontiers in …, 2021 - frontiersin.org
Background: Multiple sclerosis (MS) treatment has radically improved over the last years;
however, MS symptom management is still challenging. The novel Spasticity-Plus syndrome …

Clinical and sociodemographic profile of psychomotor agitation in mental health hospitalisation: a multicentre study

ME Garrote-Cámara, V Gea-Caballero… - International journal of …, 2022 - mdpi.com
Psychomotor agitation is characterised by an increase in psychomotor activity, restlessness
and irritability. People with psychomotor agitation respond by over-reacting to both intrinsic …

Link between temperament traits, brain neurochemistry and response to SSRI: Insights from animal model of social behavior

K Murlanova, I Michaelevski, A Kreinin… - Journal of Affective …, 2021 - Elsevier
Background Dominant-submissive relationships depend upon functionality of the neural
circuits involving monoaminergic neurotransmission. Behavioral profiles of selectively bred …